Baseimmune
PrivateLast Round
Series A
Feb 26, 2024
Total Funding Raised
$17.15M
Company Overview
Baseimmune is a biotechnology company that utilizes a proprietary deep learning AI platform to predict future pathogen mutations for the development of novel vaccines and immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baseimmune Comparables
Compare Baseimmune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Deepflare | 81% | |
| EVA Therapeutics, Inc. | 81% | |
| EVA Therapeutics, Inc. | 78% | |
Baseimmune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2024 | ||||
| Seed | Nov 2, 2021 | ||||
| Pre Seed | Apr 1, 2021 |
Key People
Founding team and executive leadership
Baseimmune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Series A |
| Hoxton Ventures | Series A, Seed |
| IQ Capital | Series A |
| Rockmount Seed Investments | Seed, Pre Seed |
| Beast Ventures | Seed, Series A |
| Maki | Seed, Pre Seed, Series A |
| The Creator Fund | Seed, Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
Unveiled a multi-pathway immunotherapy strategy for fibrosis.
- Feb 26, 2024
$11.4M round led by Merck Global Health Innovation Fund and IQ Capital.
Baseimmune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Baseimmune's valuation, stock price, and market status.